VEYVONDI

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, UK.

Active ingredients

The drug VEYVONDI contains one active pharmaceutical ingredient (API):

1	Von Willebrand factor, Recombinant, Human UNII 5PKM8P0G5I - VONICOG ALFA
	Administration of von Willebrand factor allows correction of the haemostatic abnormalities exhibited by patients who suffer from von Willebrand factor deficiency.
	Read more about Von Willebrand factor

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VEYVONDI Powder and solvent for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD10	Von Willebrand factor	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1778979, 1778980
FI	Lääkealan turvallisuus- ja kehittämiskeskus	453328, 569223
FR	Base de données publique des médicaments	65346733, 69749137
GB	Medicines & Healthcare Products Regulatory Agency	387043, 387046
IT	Agenzia del Farmaco	046994012, 046994024
LT	Valstybinė vaistų kontrolės tarnyba	1086214, 1086215
NL	Z-Index G-Standaard	15602427
NL	Z-Index G-Standaard, PRK	195960, 195979
PL	Rejestru Produktów Leczniczych	100410597, 100410611
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66931001, W66932001